Safety of Checkpoint Inhibitors for Cancer Treatment: Strategies for Patient Monitoring and Management of Immune-Mediated Adverse Events
ImmunoTargets and Therapy - New Zealand
doi 10.2147/itt.s141577
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2017
Authors
Publisher
Informa UK Limited